Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Activation of the 12/15 lipoxygenase pathway accompanies metabolic decline in db/db pre-diabetic mice.

Dobrian AD, Huyck RW, Glenn L, Gottipati V, Haynes BA, Hansson GI, Marley A, McPheat WL, Nadler JL.

Prostaglandins Other Lipid Mediat. 2018 May;136:23-32. doi: 10.1016/j.prostaglandins.2018.03.003. Epub 2018 Mar 29.

PMID:
29605541
2.

A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.

Ali MT, Martin K, Kumar AH, Cavallin E, Pierrou S, Gleeson BM, McPheat WL, Turner EC, Huang CL, Khider W, Vaughan C, Caplice NM.

Biomaterials. 2015 Nov;69:22-9. doi: 10.1016/j.biomaterials.2015.07.059. Epub 2015 Aug 3.

PMID:
26275859
3.

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.

White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR.

Cardiovasc Res. 2010 Mar 1;85(4):825-35. doi: 10.1093/cvr/cvp341. Epub 2009 Oct 19.

4.

Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.

Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, Elebring M, George SJ, McPheat WL, Jackson CL.

Cardiovasc Res. 2006 Aug 1;71(3):586-95. Epub 2006 May 10.

PMID:
16759648
5.

Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics.

Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, Calder PC, Grimble RF, Eriksson P, McPheat WL, Shearman CP, Ye S.

Stroke. 2004 Jun;35(6):1310-5. Epub 2004 Apr 8.

PMID:
15073384
6.

Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.

Rowsell S, Hawtin P, Minshull CA, Jepson H, Brockbank SM, Barratt DG, Slater AM, McPheat WL, Waterson D, Henney AM, Pauptit RA.

J Mol Biol. 2002 May 24;319(1):173-81.

PMID:
12051944
7.

MBL genotype and risk of invasive pneumococcal disease: a case-control study.

Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, Hill AV; Oxford Pneumoccocal Surveillance Group.

Lancet. 2002 May 4;359(9317):1569-73.

PMID:
12047967
8.

Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.

Kerr AR, Irvine JJ, Search JJ, Gingles NA, Kadioglu A, Andrew PW, McPheat WL, Booth CG, Mitchell TJ.

Infect Immun. 2002 Mar;70(3):1547-57.

9.

Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.

Gingles NA, Alexander JE, Kadioglu A, Andrew PW, Kerr A, Mitchell TJ, Hopes E, Denny P, Brown S, Jones HB, Little S, Booth GC, McPheat WL.

Infect Immun. 2001 Jan;69(1):426-34.

10.

A recQ family DNA helicase gene from Aspergillus nidulans.

Appleyard MV, McPheat WL, Stark MJ.

DNA Seq. 2000;11(3-4):315-9.

PMID:
11092746
11.
12.

Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.

Londono LP, Jones HB, Vie AT, McPheat WL, Booth G, Gao XM, Dougan G.

FEMS Immunol Med Microbiol. 2000 Feb;27(2):117-25.

13.

Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection.

Londoño P, Gao XM, Bowe F, McPheat WL, Booth G, Dougan G.

Microbiology. 1998 Aug;144 ( Pt 8):2291-8.

PMID:
9720052
14.

Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.

Aharony D, Little J, Powell S, Hopkins B, Bundell KR, McPheat WL, Gordon RD, Hassall G, Hockney R, Griffin R, et al.

Mol Pharmacol. 1993 Aug;44(2):356-63.

PMID:
8394992
15.
16.

Amplification of DNA by the polymerase chain reaction for the efficient diagnosis of pertussis.

Olcén P, Bäckman A, Johansson B, Esbjörner E, Törnqvist E, Bygraves J, McPheat WL.

Scand J Infect Dis. 1992;24(3):339-45.

PMID:
1509238
17.

Unknown sequence amplification: application to in vitro genome walking in Chlamydia trachomatis L2.

Copley CG, Boot C, Bundell K, McPheat WL.

Biotechnology (N Y). 1991 Jan;9(1):74-9.

PMID:
1367216
18.

Analysis of the chromosomal location of two copies of a Bordetella pertussis insertion sequence.

McPheat WL, Hanson JH, Livey I, Robertson JS.

Mol Microbiol. 1989 Jul;3(7):985-9.

PMID:
2552259
19.

Analysis of separate isolates of Bordetella pertussis repeated DNA sequences.

McPheat WL, Hanson JH, Livey I, Robertson JS.

J Gen Microbiol. 1989 Jun;135(6):1515-20.

PMID:
2559151
20.

Isolation of a repeated DNA sequence from Bordetella pertussis.

McPheat WL, McNally T.

J Gen Microbiol. 1987 Feb;133(2):323-30.

PMID:
2888834
21.

Distribution of a repeated DNA sequence in the genus "Bordetella".

McPheat WL, McNally T.

Ann Sclavo Collana Monogr. 1986;3(1-2):313-8. No abstract available.

PMID:
3426877
22.

Preliminary evidence for a pyridine nucleotide cycle in Bordetella pertussis.

McPheat WL.

Antonie Van Leeuwenhoek. 1984;50(1):33-7.

PMID:
6326669
23.

Modulation of Bordetella pertussis by nicotinic acid.

McPheat WL, Wardlaw AC, Novotny P.

Infect Immun. 1983 Aug;41(2):516-22.

24.

Supplemental Content

Loading ...
Support Center